UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(MARK ONE)
x AMENDMENT NO. 1 TO QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
AND EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED July 31, 2009
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
COMMISSION FILE NUMBER: 000-25809
APOLLO MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | | 20-8046599 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
1010 N. Central Avenue
Glendale, California 91202
(Address of principal executive offices)
(818) 507-4617
Issuer’s telephone number:
(Former Name or Former Address, if Changed Since Last Report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer ¨ | Accelerated filer ¨ |
| | |
Non-accelerated filer ¨ | Smaller reporting company x |
APOLLO MEDICAL HOLDINGS, INC.
FORM 10-Q/A
For the quarterly period ended July 31, 2009
TABLE OF CONTENTS
| PART I |
| | |
| Explanatory Note. | 1 |
Explanatory Note
This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (“Amendment No. 1”), is being filed to amend the Company’s Quarterly Report on Form 10-Q for the for the quarterly period ended July 31, 2009, previously filed on September 4, 2009 (the “Original Filing”), in order to correct one of the Company’s disclosures on the cover page of the Original Filing.
In response to an inquiry on the cover page of the Original Filing (the “Cover Page Inquiry”) on whether the Company has (i) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months, and (ii) been subject to such filing requirements for the past 90 days, the Company erroneously indicated “No.”
The Company is filing this Amendment No. 1 to change its response to the Cover Page Inquiry from “No” to “Yes,” and to correctly disclose that (i) it has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months, and (ii) it has been subject to such filing requirements for the past 90 days.
Except for the foregoing correction, this Amendment No. 1 on Form 10-Q/A does not amend or update any other information contained in the Original Filing.
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | APOLLO MEDICAL HOLDINGS, INC. |
| | |
| Date: November 9, 2009 | By: | /s/ A. NOEL DEWINTER |
| | | A. Noel DeWinter |
| | | Chief Financial Officer |
